syngeneic bone marrow transplantation immunotherapy murine B-cell lymphoma active immunization tumor-derived idiotypic immunoglobulin Recurrence underlying malignancy major cause treatment failure autologous bone marrow transplantation BMT patients lymphoma regard immunotherapeutic approach resistance residual tumor cells BMT Previous studies model system lethal B-cell lymphoma origin active immunization purified tumor-derived surface immunoglobulin Id tumor-associated antigen resistance growth Id immunization mice weeks reconstitution syngeneic bone marrow survival tumor challenge controls Low levels idiotype-specific antibody sera immunized mice early time functional studies literature immunocompetence syngeneic reconstitution incomplete recovery Immunization mice lethal irradiation syngeneic marrow reconstitution significant resistance challenge persistence host antitumor immunity total body irradiation studies feasibility id immunization conjunction bone marrow transplantation 